Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q4 2019 Earnings

30OctConfirmed

Q1 2019

Q2 2019

Q3 2019

Q4 2019

-0.59

-0.49

-0.39

-0.29

Details

Expected EPS

-0.39

Actual EPS

-0.29

Surprise EPS

0.1

Surprise Percent

+25.64%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.29 per share for Q4 2019.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.